News about the Innovation Law and Tech Program or news about faculty or students that relates to law and technology
On October 27, Professor Jacob Sherkow will be speaking at the Intellectual Property Workshop at Michigan Law School. He will be presenting a paper on the law of inducement in the pharmaceutical patent infringement cases, which is forthcoming in the Stanford Law Review. Event details are available from the University of Michigan Law School.
Professor Jacob Sherkow has published “A ‘Bare Hope of A Result’: The Second CRISPR Patent Appeal” in The CRISPR Journal. In the article, Sherkow provides an overview of the dispute to date, reviews the Federal Circuit’s recent opinion, and provides a critique of its analysis. Read the full article.
Professor Rob Kar has published “The Contractual Death and Rebirth of Privacy” in the Harvard Journal of Law & Technology. Co-authored with Xiaowei Yu, the abstract follows: This Article proposes, for the first time, the application of “shared meaning analysis” — a method of contract interpretation grounded in traditional contract principles, as developed in Pseudo-Contract […]
The regulatory framework for artificial intelligence-based medical devices needs to be improved to ensure transparency and protect patients’ health, says Sara Gerke, the Richard W. & Marie L. Corman Scholar at the University of Illinois Urbana-Champaign and expert in the ethical and legal challenges of artificial intelligence for health care. Gerke argues that the Food […]
The University of Illinois College of Law is proud to welcome Eric Baudry and Sarah Lawsky as new faculty members this fall. Baudry joins as an assistant professor of law with a specialty in tax law, poverty, and redistribution; Lawsky will serve as the L.B. Lall and Sumitra Devi Lall Professor of Law and the […]
In an analysis of a brief expected to be filed in the fall, the Patently-O blog cites the work of Professor Jacob Sherkow extensively in examining the ‘label-plus’ theory of inducement. This framework establishes that a generic drug’s label by itself cannot violate patent protections because of a congressionally authorized regulatory scheme. Sherkow’s work, in […]
In June, Professor Jacob Sherkow traveled to Denmark to present his work, “Patent Eligibility, Secure Computing, and Genomic Data Sharing,” at the ATRIP Congress at the University of Copenhagen. His presentation took place on Monday, June 23, as part of the Intellectual Property & Justice: Balancing Frameworks in Patent Law portion of the conference. Learn […]
Polygenic testing startups offer consumers the chance of a “superbaby” by screening for genetic disorders and allowing parents to select certain embryos for fertilization; however, the ethics and the science of this practice are very controversial. Speaking to The San Francisco Standard, Professor Jacob Sherkow added his expertise on the issue. “[These companies] claim to […]
One of the most concerning aspects of genetic testing company 23andMe filing for Chapter 11 bankruptcy, Professor Sara Gerke writes in a new article published in BMJ, is the range of information the company holds. Along with her co-authors, Gerke explores the issues presented by the genetic information, such as from saliva samples, self-reported health and […]
Professor Jacob Sherkow recently had the chance to present his research, “A Sociotechnical Approach to Genomic Data Security: A Comparative Legal Analysis,” to the Law, Medicine and Life Sciences group at the University of Cambridge Faculty of Law. In addition to his position at the College of Law, where he serves as director of the […]